NCT06625593 2026-04-16
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
BeOne Medicines
Phase 1 Recruiting
Clinical Trials
21 trialsNCT05566795 2026-03-02
DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)
Day One Biopharmaceuticals, Inc.
Phase 3 Recruiting
NCT03651206 2025-12-19
ROCSAN
ARCAGY/ GINECO GROUP
Phase 2/3 Recruiting
NCT06877533 2025-08-12
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
iTeos Therapeutics
Phase 1 Terminated
NCT06702566 2024-11-25
The Effect of Serum Ferritin in irAE
Tianjin Medical University Cancer Institute and Hospital
Phase NA Recruiting
NCT06368063 2024-05-08
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
Xi'an Jiaotong University
Phase 4 Recruiting
NCT06357598 2024-04-10
PILOT
The Affiliated Hospital of Qingdao University
Phase 4 Recruiting
NCT05573373 2024-01-31
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
Affiliated Hospital of Jiangnan University
Phase 1 Unknown
NCT04688801 2022-11-16
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
The Second Hospital of Shandong University
Phase NA Recruiting
NCT04004910 2022-03-24
A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients
Immunicom Inc
Phase 1/2 Unknown
NCT04943029 2021-09-02
NEOSUN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT00439296 2021-03-17
ABT-751 With Chemotherapy for Relapsed Pediatric ALL
Therapeutic Advances in Childhood Leukemia Consortium
Phase 1/2 Terminated
NCT00831766 2020-12-22
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
NCT03591276 2020-10-23
KEYDOX
Shaare Zedek Medical Center
Phase 1/2 Recruiting
NCT04278469 2020-02-20
Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy
Gencurix, Inc.
Phase NA Recruiting
NCT00617409 2019-11-08
To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT03799679 2019-01-10
Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer
Fudan University
Phase 4 Unknown
NCT03777930 2018-12-19
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
Shenzhen Fifth People's Hospital
Phase 4 Unknown
NCT03611179 2018-08-02
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Assiut University
Phase 2 Unknown
NCT02462265 2018-04-18
Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients
Oshadi Drug Administration
Phase 2 Suspended
NCT02821533 2017-08-22
Chemoembolization for Hepatocellular Carcinoma
Chinese University of Hong Kong
Phase 2 Terminated